Miranda Tan, DO
Sleep Medicine · New York
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · Trustees of Columbia University in the City of New York · Stanford Health Care
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,746
Medicare paid this office $28,746 for 291 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 87 | $8,201 | $94 |
| Return visit (30+ min) | 88 | $7,725 | $83 |
| Sleep study in sleep lab (6 years or older) | 57 | $5,820 | $102 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 28 | $2,827 | $101 |
| Sleep study including heart rate, breathing, and sleep time | 41 | $1,505 | $35 |
See all 6 services
| New patient visit (45+ min) | 87 | $8,201 | $94 |
| Return visit (30+ min) | 88 | $7,725 | $83 |
| Sleep study in sleep lab (6 years or older) | 57 | $5,820 | $102 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 28 | $2,827 | $101 |
| Sleep study including heart rate, breathing, and sleep time | 41 | $1,505 | $35 |
| Short return visit (20+ min) | 17 | $788 | $46 |
Who their Medicare patients are
291 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 8% · Women 48% · Also on Medicaid 16% · Health risk score 1.21. At or below the middle of the specialty; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 69% · Coronary heart disease 29% · Diabetes 24% · Depression 23% · Chronic kidney disease 22% · Atrial fibrillation 19% · Heart failure 16% · Cancer 16% · COPD 11% · Stroke 11% · Dementia 7%.
The office billed $249,570, Medicare allowed $41,657 and paid $28,746; for 337 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 291 | 337 | 73 | 1.21 | $249,570 | $28,746 |
| 2023 | 270 | 367 | 72 | 1.17 | $228,343 | $37,207 |
| 2022 | 39 | 80 | 69 | 2.31 | $48,255 | $7,403 |
| 2021 | 113 | 205 | 70 | 2.09 | $131,240 | $21,812 |
| 2020 | 130 | 241 | 69 | 2.42 | $107,975 | $15,877 |
| 2019 | 272 | 649 | 72 | 2.68 | $140,920 | $21,379 |
| 2018 | 153 | 296 | 71 | 2.13 | $78,170 | $13,384 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| New patient visit (45+ min) | 93 | $10,759 | $116 |
| Return visit (30+ min) | 95 | $8,829 | $85 |
| New patient visit (60+ min) | 42 | $6,384 | $152 |
| Sleep study in sleep lab (6 years or older) | 56 | $5,962 | $106 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $2,983 | $110 |
| Sleep study including heart rate, breathing, and sleep time | 32 | $1,166 | $36 |
2022: 4 services
| Return visit (30+ min) | 19 | $2,164 | $87 |
| Long return visit (40+ min) | 11 | $2,025 | $119 |
| New patient visit (60+ min) | 12 | $1,966 | $164 |
| Sleep study including heart rate, breathing, airflow, and effort | 12 | $445 | $37 |
2021: 5 services
| Long return visit (40+ min) | 66 | $13,011 | $133 |
| New patient visit (60+ min) | 21 | $3,484 | $166 |
| Return visit (30+ min) | 20 | $1,750 | $83 |
| Short return visit (20+ min) | 17 | $1,195 | $57 |
| Sleep study including heart rate, breathing, airflow, and effort | 29 | $1,190 | $40 |
2020: 7 services
| New patient visit (45+ min) | 24 | $2,627 | $109 |
| Return visit (30+ min) | 23 | $1,842 | $71 |
| Short return visit (20+ min) | 32 | $1,831 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,822 | $96 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 17 | $783 | $46 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $672 | $48 |
| Sleep study including heart rate, breathing, airflow, and effort | 12 | $499 | $42 |
2019: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,595 | $92 |
| New patient visit (45+ min) | 25 | $2,879 | $115 |
| Long return visit (40+ min) | 23 | $2,464 | $99 |
| Short return visit (20+ min) | 25 | $1,542 | $45 |
| Test for exercise-induced lung stress | 65 | $1,332 | $20 |
| Return visit (30+ min) | 11 | $908 | $70 |
| Test to examine how well the lungs exchange gases | 92 | $761 | $8 |
| Ultrasound scan of chest | 29 | $746 | $24 |
| Test to determine lung volumes using sensors | 62 | $694 | $11 |
| Sleep study including heart rate, breathing, airflow, and effort | 14 | $662 | $44 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 57 | $655 | $11 |
| Test for exercise-induced lung stress | 31 | $626 | $20 |
| Test to measure expiratory airflow and volume | 42 | $323 | $8 |
| Test to examine how well the lungs exchange gases | 39 | $316 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $253 | $11 |
| Test to measure expiratory airflow and volume | 17 | $128 | $8 |
2018: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,637 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,435 | $181 |
| Test for exercise-induced lung stress | 45 | $927 | $20 |
| Ultrasound scan of chest | 25 | $647 | $24 |
| Test for exercise-induced lung stress | 28 | $564 | $20 |
| Test to determine lung volumes using sensors | 32 | $347 | $11 |
| Test to examine how well the lungs exchange gases | 41 | $332 | $8 |
| Test to measure expiratory airflow and volume | 14 | $105 | $8 |
Medicaid work
$2,558 in 2023
Medicaid paid $2,558 for 36 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 24 | $1,748 |
| New patient visit (60+ min) | 12 | $810 |
| 2023 | 36 | 2 | 12 | $2,558 |
Money from drug and device companies
$53 in 2025
| 2025 | 1 | 1 | None | $53 |
| 2023 | 3 | 4 | $2,610 | $2,784 |
| 2019 | 1 | 1 | None | $100 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axsome Therapeutics | Sunosi | $53 | 1 payment
|
See the published payment
| Axsome Therapeutics | Meals · 2025-03-21 | Sunosi | $53 |
See earlier years (2023, 2019)
2023: $2,784
| Eisai | None | $2,610 | 1 payment
|
| ZOLL Respicardia | Remede System | $141 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $33 | 2 payments
|
2019: $100
| Genentech USA | Esbriet | $100 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376862821
- Licence
- CA 20A20250, NY 270140
- Trained
- New York College of Osteo Medicine of New York Institute of Technology, 2010
- Group
- Trustees of Columbia University in the City of New York · Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 622 W 168th St Ph 859, New York, NY, 10032
- NPI first listed
- 2010-05-24
- NPI last updated
- 2026-04-13
- NPI record certified
- 2026-04-13
This is when the NPI record was last certified, not a medical board exam.